Immunotherapy and Immune-related Toxicity in Lung Cancer

Part of the Oncology and TR Grand Rounds Series - Jarushka Naidoo, MB, BCH identifies single agent immunotherapy and chemo- immunotherapy in first-line NSCLC. Dr. Jarushka also reviews combination immune checkpoint blockades in first-line and other immune-related toxicities.

Created by

Johns Hopkins Greater Washington Area

Related Presenters

Jarushka Naidoo, M.B.B.Ch.

Jarushka Naidoo, M.B.B.Ch.

Assistant Professor of Oncology

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Bloomberg-Kimmel Institute for Cancer Immunotherapy

View full profile